EBITDA of Fresenius 2013-2022

Published by
Conor Stewart,
Jun 13, 2023
This statistic shows the EBITDA of Fresenius SE from 2013 to 2022. In 2013, the German medical technology company totaled around 3.9 billion euros of EBITDA worldwide, by 2022 the company's EBITDA had increased to over 6.8 billion euros.

EBITDA of the Fresenius Group from 2013 to 2022 (in million euros)*

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2023

Region

Worldwide

Survey time period

2013 to 2022

Supplementary notes

EBITDA = earnings before interest, taxes, depreciation, and amortization.
* 2017-2022 before special items

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Fresenius "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Fresenius

Market position

4

Key facts

7

Business distribution

4

Competitors

4

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Medical technology in South KoreaMedical technologyMedical technology in ChinaHealth care in South Korea Pharmaceutical industry in South Korea
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu